Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg

• Status: Recruiting
• Trial end date: 2026-09-22
• Target enrollment: 0
• Participant gender: All

Summary

the investigators would like to compare the differences between roschvastin and atovastatin in patients who require high-dose statin/ejetimib to undergo a new generation of drug elution stent implantation for cardiovascular disease and maintain LDL cholesterol below 55 mg/dL.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Yonsei University
• Collaborator: dotter
• Treatments: Ezetimibe

Criteria

Inclusion Criteria:

1. 19 years of age or older

2. Patients who underwent a new generation of drug elution stent implantation for cardiovascular disease

Exclusion Criteria:

1. LDL cholesterol levels below 55 mg/dL without statin treatment

2. Serum AST/ALT with an acute liver disease within a month or a normal upper limit that is not continuously explained

3. Allergies or overreactions to statins

4. Estimated Dawn of Less than 1 Year

5. If it is determined that follow-up is not possible for more than one year

6. Pregnancy